Short Interest in ABVC BioPharma, Inc. Grows By 8.1

ABVC Stock  USD 0.53  0.05  8.62%   
About 61% of ABVC Biopharma's investor base is looking to short. The analysis of the overall investor sentiment regarding ABVC Biopharma suggests that many traders are alarmed. The current market sentiment, together with ABVC Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use ABVC Biopharma stock news signals to limit their universe of possible portfolio assets.
  
ABVC BioPharma, Inc. was the target of a large increase in short interest in August. As of August 31st, there was short interest totalling 137,500 shares, an increase of 8.1 percent from the August 15th total of 127,200 shares. Approximately 1.3 percent of the shares of the stock are short sold. Based

Read at thelincolnianonline.com
news
  

ABVC Biopharma Fundamental Analysis

We analyze ABVC Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABVC Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABVC Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

ABVC Biopharma is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

ABVC Biopharma Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ABVC Biopharma stock to make a market-neutral strategy. Peer analysis of ABVC Biopharma could also be used in its relative valuation, which is a method of valuing ABVC Biopharma by comparing valuation metrics with similar companies.

Peers

ABVC Biopharma Related Equities

SABSSAB Biotherapeutics   6.05   
0%
38.0%
ANEBAnebulo Pharmaceuticals   0.61   
3.0%
0%
MNPRMonopar Therapeutics   2.78   
17.0%
0%
RNXTRenovoRx   3.65   
23.0%
0%
INDPIndaptus Therapeutics   3.96   
25.0%
0%
NTRBNutriband   4.04   
26.0%
0%
ELDNEledon Pharmaceuticals   4.66   
30.0%
0%
LGVNLongeveron LLC   4.74   
30.0%
0%
ALRNAileron Therapeutics   5.85   
37.0%
0%
QNRXQuoin Pharmaceuticals   6.06   
39.0%
0%
KTTAPasithea Therapeutics   6.35   
40.0%
0%
FBRXForte Biosciences   6.40   
41.0%
0%
AKTXAkari Therapeutics   9.22   
59.0%
0%
ADTXAditxt   10.53   
67.0%
0%
VRAXVirax Biolabs   15.52   
100.0%
0%

Complementary Tools for ABVC Stock analysis

When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites